Sumitomo Mitsui Trust Group Inc. Grows Stake in Humana Inc. (NYSE:HUM)

Sumitomo Mitsui Trust Group Inc. grew its stake in shares of Humana Inc. (NYSE:HUM) by 1.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 330,906 shares of the insurance provider’s stock after purchasing an additional 5,497 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Humana were worth $83,954,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of HUM. International Assets Investment Management LLC increased its position in shares of Humana by 261,025.1% during the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock worth $2,340,660,000 after acquiring an additional 738,701 shares during the last quarter. FMR LLC grew its stake in Humana by 23.4% during the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after purchasing an additional 643,291 shares in the last quarter. Thrivent Financial for Lutherans increased its holdings in Humana by 55.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider’s stock worth $190,145,000 after purchasing an additional 214,535 shares during the last quarter. Retirement Systems of Alabama raised its position in shares of Humana by 735.9% in the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after purchasing an additional 192,801 shares in the last quarter. Finally, Pzena Investment Management LLC boosted its stake in shares of Humana by 8.1% during the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock valued at $793,830,000 after buying an additional 187,903 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on HUM. Barclays lifted their price target on shares of Humana from $253.00 to $255.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 22nd. Wells Fargo & Company cut their target price on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. Truist Financial increased their price target on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Morgan Stanley boosted their price objective on Humana from $288.00 to $301.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. Finally, Bank of America raised Humana from an “underperform” rating to a “neutral” rating and increased their target price for the stock from $247.00 to $308.00 in a report on Wednesday, November 6th. Nineteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, Humana currently has an average rating of “Hold” and an average target price of $297.68.

Humana Price Performance

Shares of NYSE:HUM opened at $274.06 on Monday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm’s 50 day moving average is $274.21 and its two-hundred day moving average is $298.14. The firm has a market capitalization of $33.00 billion, a P/E ratio of 24.27, a PEG ratio of 2.11 and a beta of 0.56. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46.

Insider Activity at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.32% of the stock is owned by insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.